DK2922563T3 - Cd44v6-afledte peptider til behandling af metastaserende kræfttyper - Google Patents

Cd44v6-afledte peptider til behandling af metastaserende kræfttyper Download PDF

Info

Publication number
DK2922563T3
DK2922563T3 DK13798617.0T DK13798617T DK2922563T3 DK 2922563 T3 DK2922563 T3 DK 2922563T3 DK 13798617 T DK13798617 T DK 13798617T DK 2922563 T3 DK2922563 T3 DK 2922563T3
Authority
DK
Denmark
Prior art keywords
cd44v6
treatment
metastatic cancer
derived peptides
cancer types
Prior art date
Application number
DK13798617.0T
Other languages
Danish (da)
English (en)
Inventor
Alexandra Matzke
Helmut Ponta
Véronique Orian-Rousseau
Original Assignee
Karlsruher Inst Technologie
Amcure Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karlsruher Inst Technologie, Amcure Gmbh filed Critical Karlsruher Inst Technologie
Application granted granted Critical
Publication of DK2922563T3 publication Critical patent/DK2922563T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK13798617.0T 2012-11-21 2013-11-21 Cd44v6-afledte peptider til behandling af metastaserende kræfttyper DK2922563T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1220889.8A GB201220889D0 (en) 2012-11-21 2012-11-21 CD44v6-derived peptides for treating metastasizing cancers
PCT/EP2013/074404 WO2014079943A1 (en) 2012-11-21 2013-11-21 Cd44v6-derived peptides for treating metastasizing cancers

Publications (1)

Publication Number Publication Date
DK2922563T3 true DK2922563T3 (da) 2020-01-20

Family

ID=47521460

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13798617.0T DK2922563T3 (da) 2012-11-21 2013-11-21 Cd44v6-afledte peptider til behandling af metastaserende kræfttyper

Country Status (13)

Country Link
US (1) US9593146B2 (https=)
EP (1) EP2922563B1 (https=)
JP (1) JP2016501858A (https=)
AU (1) AU2013349703B2 (https=)
CA (1) CA2892147A1 (https=)
DK (1) DK2922563T3 (https=)
ES (1) ES2765037T3 (https=)
GB (1) GB201220889D0 (https=)
HU (1) HUE047126T2 (https=)
IL (1) IL238606B (https=)
LT (1) LT2922563T (https=)
SI (1) SI2922563T1 (https=)
WO (1) WO2014079943A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201421647D0 (en) * 2014-12-05 2015-01-21 Amcure Gmbh And Ruprecht-Karls-Universitat And Karlsruher Institut F�R Technologie CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases
EP3466963A1 (en) 2017-10-05 2019-04-10 Suigeneris Farmacosmetics, S.L. Anticancer peptides and uses thereof
KR102194025B1 (ko) 2017-12-15 2020-12-22 경북대학교 산학협력단 CD44v6에 결합하는 펩타이드 및 이의 용도
US11744883B2 (en) 2017-12-22 2023-09-05 Hipra Scientific, S.L.U. Intradermal combination vaccine against mycoplasma and porcine circovirus
EP4464714A1 (en) 2023-05-19 2024-11-20 Karlsruher Institut für Technologie Screening method for cell-repelling peptides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696229A (en) 1995-03-16 1997-12-09 The University Of Virginia Patent Foundation Polypeptide with laminin cell adhesion and morphogenesis activity
DE19540515C1 (de) * 1995-10-31 1997-02-06 Boehringer Ingelheim Int Tumortherapie durch adoptiven Transfer CD44v-spezifischer zytotoxischer T-Lymphozyten
EP1258255A1 (en) 2001-05-18 2002-11-20 Boehringer Ingelheim International GmbH Conjugates of an antibody to CD44 and a maytansinoid
JP2003089700A (ja) 2001-09-18 2003-03-28 Life Science Management:Kk ペプチド
EP1417974A1 (en) * 2002-11-08 2004-05-12 Boehringer Ingelheim International GmbH Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and radiotherapy
AR046774A1 (es) 2003-12-24 2005-12-21 Boehringer Ingelheim Pharma Formulacion liofilizada de conjugados de anticuerpos
EP1647556B1 (en) * 2004-10-14 2010-05-19 Karlsruher Institut für Technologie Peptidic compounds and derivatives thereof for the treatment of human diseases through inhibition of signaling via growth factors
EP2218457B1 (en) * 2009-02-16 2011-09-07 Karlsruher Institut für Technologie CD44v6 peptides as inhibitors of bacterial infections
EP2266593A1 (en) * 2009-06-24 2010-12-29 Karlsruher Institut für Technologie Use of CD44v6 in the treatment of ophthalmic diseases
WO2011022335A1 (en) * 2009-08-21 2011-02-24 Mount Sinai School Of Medicine Of New York University Methods of using cd44 fusion proteins to treat cancer

Also Published As

Publication number Publication date
GB201220889D0 (en) 2013-01-02
WO2014079943A1 (en) 2014-05-30
ES2765037T3 (es) 2020-06-05
HUE047126T2 (hu) 2020-04-28
SI2922563T1 (sl) 2020-04-30
EP2922563A1 (en) 2015-09-30
IL238606A0 (en) 2015-06-30
LT2922563T (lt) 2020-03-25
US9593146B2 (en) 2017-03-14
IL238606B (en) 2019-07-31
AU2013349703B2 (en) 2016-12-22
AU2013349703A1 (en) 2015-07-09
JP2016501858A (ja) 2016-01-21
EP2922563B1 (en) 2019-10-30
CA2892147A1 (en) 2014-05-30
US20150183826A1 (en) 2015-07-02

Similar Documents

Publication Publication Date Title
IL289300A (en) Combination therapy for treating cancer
DK2897620T3 (da) Fremgangsmåde til behandling af cancer
DK3033086T3 (da) Kombinationsterapi til behandling af cancer
DK2818482T3 (da) Farmaceutisk sammensætning til behandling af cancer
DK2824114T3 (da) Farmaceutisk sammensætning til behandling af cancer
DK3076976T3 (da) Fremgangsmåder til behandling af cancer
DK3043816T3 (da) Anti-b7-h1-antistoffer til behandling af tumorer
DK3046583T3 (da) Viruslignende partikelkonjugater til behandling af tumorer
DK3329884T3 (da) Implanterbar indretning til behandling af glaukom
DK2861240T3 (da) Nukleinsyrer til behandling af allergier
DK3054976T3 (da) Anvendelse af semaphorin-4d-bindende molekyler til behandling af aterosklerose
HUE046667T2 (hu) Rák kombinatív kezelése
HUE045314T2 (hu) Kombinációs terápia rák kezelésére
DK2976359T4 (da) Fremgangsmåder til behandling af osteogenesis imperfecta
PL2839230T3 (pl) Instalacja do obróbki obiektów
DK2836460T3 (da) Fremgangsmåde til fremstilling af graphen
DK3511004T3 (da) Kombineret præparat til behandling af cancer
DK2692448T3 (da) Brusehoved
DK3305285T3 (da) Anti-androgener til behandlingen af ikke-metastatisk kastrationsresistent prostatakræft
EP3967315C0 (en) AKKERMANSIA MUCINIPHILA FOR THE TREATMENT OF CANCER
DK2825558T3 (da) Kombinationsterapi til behandling af ovariecancer
DK3608421T3 (da) Fremgangsmåde til screening for colorektal cancer
LT2914254T (lt) Kombinacinės terapijos chemoresistencinių vėžių gydymui
DK2906219T3 (da) Orvepitant til behandling af kronisk pruritus
DK3290035T3 (da) Procaspase-kombinationsterapi til behandling af cancer